Press Release

IP Infusion Collaborated with NTT for the Development of Beluganos — a New White Box Network Operating System to Realize NTT's IOWN Concept — and Commences Sales and Support for Global Markets

SANTA CLARA, Calif., March 28, 2023 – IP Infusion, a leading provider of open network software and solutions for wireline and mobile network operators, announced that it had provided technical support for the development of Beluganos*1 — a new network operating system (NOS) for white box solutions*2 to realize NTT Corporation (NTT)'s IOWN*3 concept — and will commence sales and support for global markets on March 31 with the cooperation of NTT and NTT Advanced Technology Corporation (NTT-AT), the core technology company of NTT Group.

Beluganos includes various advanced functions, such as routing and switching capabilities that can replace legacy equipment with a choice of open networking hardware and software solutions, in addition to NTT's commercial network operation expertise. Because of its disaggregated design that separates software functions from hardware, Beluganos reduces operating and capital expenditure costs while simultaneously enabling network innovations for network operators. IP Infusion, a member of IOWN Global Forum, provided technical support for the development of Beluganos and will scale the IOWN concept around the world through global sales of Beluganos.

"We are incredibly proud to support NTT in the development, go-to-market and distribution of Beluganos," said Atsushi Ogata, CEO and President of IP Infusion. "This project demonstrates our ongoing commitment to fostering broad access and high quality software solutions that further innovation and lower total cost of ownership."

IP Infusion 소개

IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.

IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.

Explanation of Terminology

*1 Beluganos

 For more information on Beluganos, please refer to NTT's press release.

https://group.ntt/en/newsrelease/2023/03/28/230328b.html

*2 White box solution

A solution in which software functions are separated (disaggregated) from hardware, and general-purpose equipment can be freely selected. This enables flexible network configurations, significant cost reduction and rapid implementation of new functions and services.

*3 IOWN

IOWN stands for Innovative Optical and Wireless Network and a concept proposed by NTT for networks and information processing infrastructure. Since January 2021, IP Infusion has been a General Member of the IOWN Global Forum (Established in Jan. 2020), an international forum promoted by companies and organizations supporting the IOWN vision.

https://www.rd.ntt/e/iown/

https://iowngf.org/

 

IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. Beluganos is a registered trademark of NTT. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.

미디어 문의

Katherine Verducci

1903 PR

kverducci@1903pr.com

408.429.5779

IP Infusion 소개

IP Infusion은 오픈 네트워킹 소프트웨어의 선도적 공급업체로, 서비스 사업자, 데이터센터, AI 패브릭 네트워크를 위한 통신사업자급 네트워크 운영체제 OcNOS를 제공합니다. 1999년부터 쌓아 온 네트워킹 전문성과 전 세계 600개 이상의 사업자를 바탕으로, IP Infusion은 Edgecore Networks, UfiSpace, Celestica 등 파트너의 검증된 개방형 하드웨어에서 개방적이고 멀티벤더이며 비용 효율적이고 유연한 네트워크 인프라를 구현합니다. IP Infusion은 ACCESS CO., LTD.(도쿄증권거래소: 4813)의 전액 출자 자회사입니다.

미디어 문의

For press inquiries, analyst briefings, or media materials, please 팀에 문의 or email pr@ipinfusion.com.

미래예측 진술

본 보도자료에는 IP Infusion의 제품, 기술 및 계획에 관한 미래예측 진술이 포함될 수 있습니다. 미래예측 진술은 공개일 현재 이용 가능한 정보에 기초하며 위험과 불확실성을 수반합니다. 실제 결과는 다를 수 있습니다. 제품 계획, 기능, 출시 시기 및 제공 여부는 예고 없이 변경될 수 있으며 약정, 약속 또는 법적 의무를 구성하지 않습니다. IP Infusion은 미래예측 진술을 갱신할 의무를 지지 않습니다.